Zenas BioPharma Inc. (ZBIO)

AI Score

Unlock

8.97

0.64 (7.68%)

At close: Apr 17, 2025, 3:59 PM

8.44

-5.86%

After-hours: Apr 17, 2025, 07:50 PM EDT

Zenas BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Revenue	5M	n/a	50M	50M	50M	50M	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	5M	n/a	50M	50M	50M	50M	n/a	n/a	n/a
Operating Income	-163.89M	-133.04M	-56.44M	-45.64M	-37.15M	-31.36M	-66.98M	-38.08M	-18.99M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-156.56M	-128.67M	-54.45M	-45.52M	-36.82M	-31.53M	-67.14M	-38.09M	-18.99M
Net Income	-156.99M	-128.97M	-54.76M	-45.83M	-37.12M	-31.53M	-67.14M	-38.09M	-18.99M
Selling & General & Admin	29.75M	22.64M	20.21M	18.31M	17.11M	15.98M	10.95M	6.96M	3.22M
Research & Development	139.14M	110.4M	86.22M	67.33M	60.03M	55.38M	46.03M	31.11M	15.77M
Other Expenses	n/a	n/a	n/a	10M	10M	10M	10M	n/a	n/a
Operating Expenses	168.89M	133.04M	106.44M	95.64M	87.15M	81.36M	66.98M	38.08M	18.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	168.89M	133.04M	106.44M	95.64M	87.15M	81.36M	66.98M	38.08M	18.99M
Income Tax Expense	429K	301K	301K	301K	301K	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	41.79M	41.78M	38.32M	38.32M	38.32M	41.78M	38.32M	38.32M	38.32M
Shares Outstanding (Diluted)	41.79M	41.78M	38.32M	38.32M	38.32M	41.78M	38.32M	38.32M	38.32M
EPS (Basic)	-3.9	-3.28	-1.51	-1.28	-1.05	-0.91	-1.76	-1	-0.5
EPS (Diluted)	-3.9	-3.28	-1.51	-1.28	-1.05	-0.91	-1.76	-1	-0.5
EBITDA	-163.75M	-132.91M	-56.31M	-35.52M	-27.03M	-21.25M	-56.9M	-38.02M	-18.96M
EBIT	-163.89M	-133.04M	-56.44M	-35.64M	-27.15M	-21.36M	-56.98M	-38.08M	-18.99M
Depreciation & Amortization	137K	134K	124K	118K	113K	108K	82K	53K	25K